Barcelona, 11th September, 2017 – The Optogenerapy consortium will be gathered together for its second meeting after the project’s kick-off in February. The meeting, hosted by the project’s partner ETHZ, the Swiss Federal Institute of Technology Zurich, will take place in Basel on September 14th and 15th. The first six months of the project have been busy in defining specifications and designing the first pieces of...
Read More
Barcelona 20th February, 2017 - Researchers from eleven institutions and companies in seven different European countries met at Eurecat’s facilities in Cerdanyola del Vallès (Barcelona) to launch the Optogenerapy project, which aims to develop optogenetic cellular therapy implants as a new treatment for Multiple Sclerosis. The devices, based on technology developed at the Swiss Federal Institute of Technology in Basel, member of the consortium, will enable the...
Read More